Hi ID2T,
We are on the same page. I privately floated the idea of approaching dog food manfacturers with Roger in 2020 and again recently with MT.
They did not discount the suggestion. Rapamycin is currently being examined in the US for potential life extension in canines.
I firmly believe using monepantel as a trace dog food additive would square the circle of how to prevent humans taking a doggie tablet.
Dog food additives only have to be GRAS (generally recognised as safe). Big tick for MPL.
It could be a source of huge ongoing royalties.
Perhaps it will seriously be evaluated when the time is right.
Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-62
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |